Publications

Detailed Information

Dual effects of Helicobacter pylori vacuolating cytotoxin on human eosinophil apoptosis in early and late periods of stimulation

DC Field Value Language
dc.contributor.authorKim, Jung Mogg-
dc.contributor.authorKim, Joo Sung-
dc.contributor.authorLee, Jin Young-
dc.contributor.authorSim, Young-Suk-
dc.contributor.authorOh, Yu-Kyoung-
dc.contributor.authorKang, Ju Seop-
dc.contributor.authorKim, Nayoung-
dc.contributor.authorKim, Sunil-
dc.contributor.authorJung, Hyun Chae-
dc.contributor.authorYoun, Jeehee-
dc.contributor.authorYoon, Ho Joo-
dc.contributor.authorKim, Young-Jeon-
dc.date.accessioned2012-05-29T02:22:51Z-
dc.date.available2012-05-29T02:22:51Z-
dc.date.issued2010-06-
dc.identifier.citationEUROPEAN JOURNAL OF IMMUNOLOGY; Vol.40 6; 1651-1662ko_KR
dc.identifier.issn0014-2980-
dc.identifier.urihttps://hdl.handle.net/10371/76521-
dc.description.abstractAlthough Helicobacter pylori infections of the gastric mucosa are characterized by the infiltration of inflammatory cells such as eosinophils, the responses of eosinophils to H. pylori vacuolating cytotoxin (VacA) have not been fully elucidated. This study investigates the role of VacA in the apoptosis of human eosinophils. We treated human eosinophils with purified H. pylori VacA and observed that induction of apoptosis is a relatively late event. Expression of cellular inhibitor of apoptosis protein (c-IAP)-2 was upregulated during the early period of VacA stimulation, and transfection with c-IAP2 siRNA augmented apoptotic cell death. VacA caused the translocation of cytoplasmic Bax to the mitochondria and increased cytochrome c release from mitochondria in eosinophils. Transfection of an EoL-1 eosinophil cell line with Bax siRNA decreased the release of cytochrome c and DNA fragmentation. Furthermore, apoptosis facilitated by Bax and cytochrome c was primarily regulated by p38 MAPK in VacA-treated eosinophils. These results suggest that the exposure of human eosinophils to H. pylori VacA induces the early upregulation of c-IAP2 and a relatively late apoptotic response, with the apoptosis progressing through a sequential pathway that includes p38 MAPK activation, Bax translocation, and cytochrome c release.ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-V C H VERLAG GMBHko_KR
dc.subjectApoptosisko_KR
dc.subjectH. pylori vacuolating cytotoxinko_KR
dc.subjectEosinophilsko_KR
dc.titleDual effects of Helicobacter pylori vacuolating cytotoxin on human eosinophil apoptosis in early and late periods of stimulationko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor김정목-
dc.contributor.AlternativeAuthor김주성-
dc.contributor.AlternativeAuthor이진영-
dc.contributor.AlternativeAuthor심영숙-
dc.contributor.AlternativeAuthor김영전-
dc.contributor.AlternativeAuthor오유경-
dc.contributor.AlternativeAuthor윤호주-
dc.contributor.AlternativeAuthor강주섭-
dc.contributor.AlternativeAuthor윤지희-
dc.contributor.AlternativeAuthor김나영-
dc.contributor.AlternativeAuthor정현채-
dc.contributor.AlternativeAuthor김선일-
dc.identifier.doi10.1002/eji.200939882-
dc.citation.journaltitleEUROPEAN JOURNAL OF IMMUNOLOGY-
dc.description.citedreferenceFranchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703-
dc.description.citedreferenceShen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697-
dc.description.citedreferenceBergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070-
dc.description.citedreferenceLee JY, 2009, J MOL MED-JMM, V87, P169, DOI 10.1007/s00109-008-0415-2-
dc.description.citedreferenceFriboulet L, 2008, NEOPLASIA, V10, P1183, DOI 10.1593/neo.08590-
dc.description.citedreferencePiazuelo MB, 2008, HUM PATHOL, V39, P1360, DOI 10.1016/j.humpath.2008.01.012-
dc.description.citedreferenceKim JM, 2008, EUR J IMMUNOL, V38, P2190, DOI 10.1002/eji.200838191-
dc.description.citedreferenceWong WWL, 2008, IUBMB LIFE, V60, P390, DOI 10.1002/iub.51-
dc.description.citedreferenceHogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x-
dc.description.citedreferenceKim JM, 2008, LAB INVEST, V88, P541, DOI 10.1038/labinvest.2008.16-
dc.description.citedreferenceKNUDSON CM, 2008, METH MOL B, V414, P95-
dc.description.citedreferenceMueller S, 2008, BEST PRACT RES CL GA, V22, P425, DOI 10.1016/j.bpg.2007.12.008-
dc.description.citedreferenceLee JY, 2007, J MOL MED-JMM, V85, P1393, DOI 10.1007/s00109-007-0237-7-
dc.description.citedreferenceSheng G, 2007, AM J PHYSIOL-GASTR L, V293, pG599, DOI 10.1152/ajpgi.00182.2007-
dc.description.citedreferenceWilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008-
dc.description.citedreferenceKim JM, 2007, INFECT IMMUN, V75, P3373, DOI 10.1128/IAI.01940-06-
dc.description.citedreferenceGomez-Lazaro M, 2007, MOL PHARMACOL, V71, P736, DOI 10.1124/mol.106.030718-
dc.description.citedreferenceKempkensteffen C, 2007, INT J CANCER, V120, P1081, DOI 10.1002/ijc.22416-
dc.description.citedreferenceAntignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004-
dc.description.citedreferenceEr E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032-
dc.description.citedreferenceKim JM, 2006, EUR J IMMUNOL, V36, P2446, DOI 10.1002/eji.200535808-
dc.description.citedreferenceKusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05-
dc.description.citedreferenceYamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200-
dc.description.citedreferenceLu H, 2005, CURR OPIN GASTROEN, V21, P653-
dc.description.citedreferenceGauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398-
dc.description.citedreferenceLi DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010-
dc.description.citedreferenceVaux DL, 2005, CELL DEATH DIFFER, V12, P1205, DOI 10.1038/sj.cdd.4401696-
dc.description.citedreferenceKim JM, 2005, EUR J IMMUNOL, V35, P2648, DOI 10.1002/eji.200526321-
dc.description.citedreferenceNakayama M, 2004, J BIOL CHEM, V279, P7024, DOI 10.1074/jbc.M308898200-
dc.description.citedreferenceVAN LA, 2004, FASEB J, V18, P1946-
dc.description.citedreferenceAdams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903-
dc.description.citedreferenceNishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100-
dc.description.citedreferenceYang YL, 2003, FASEB J, V17, P790-
dc.description.citedreferenceKIM JM, 2003, AM J PHYSIOL-GASTR L, V285, P1171-
dc.description.citedreferenceBrito GAC, 2002, J INFECT DIS, V186, P1438-
dc.description.citedreferenceKalia N, 2002, GUT, V51, P641-
dc.description.citedreferenceSalvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830-
dc.description.citedreferenceDewson G, 2001, BLOOD, V98, P2239-
dc.description.citedreferenceKim JM, 2001, CLIN EXP IMMUNOL, V123, P421-
dc.description.citedreferenceGao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4-
dc.description.citedreferenceErjefalt JS, 2000, AM J RESP CRIT CARE, V161, P2074-
dc.description.citedreferenceTepes B, 1999, J PATHOL, V188, P24-
dc.description.citedreferenceKim JM, 1998, J CLIN INVEST, V102, P1815-
dc.description.citedreferenceKodama K, 1998, J GASTROENTEROL, V33, P14-
dc.description.citedreferenceRudi J, 1998, J CLIN MICROBIOL, V36, P944-
dc.description.citedreferenceGon S, 1997, J LEUKOCYTE BIOL, V62, P309-
dc.description.citedreferenceKroemer G, 1997, NAT MED, V3, P614-
dc.description.citedreferenceHatz RA, 1996, SCAND J GASTROENTERO, V31, P222-
dc.description.citedreferenceDEBERNARD M, 1995, J BIOL CHEM, V270, P23937-
dc.description.citedreferenceGENTA RM, 1993, MODERN PATHOL, V6, P281-
dc.description.citedreferenceMCGOVERN TW, 1991, DIGEST DIS SCI, V36, P435-
dc.description.tc3-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share